Charles Kenneth Meshul

Behavioral Neuroscience Oregon Health and Science University, Portland, OR 
Glutamate, Basal Ganglia, Parkinson's Disease, Exercise, Drug Abuse
"Charles Meshul"
Mean distance: 14.69 (cluster 6)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Xu M, Bohlen JK, Moore C, et al. (2019) Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism. Journal of Neuroscience Research
Churchill MJ, Cantu MA, Kasanga EA, et al. (2019) Glatiramer acetate reverses motor dysfunction and the decrease in tyrosine hydroxylase levels in a mouse model of Parkinson's disease. Neuroscience
Shimamoto A, Rappeneau V, Munjal H, et al. (2018) Glutamate-glutamine transfer and chronic stress-induced sex differences in cocaine responses. Neuroscience
Elliott JE, De Luche SE, Churchill MJ, et al. (2018) Dietary therapy restores glutamatergic input to orexin/hypocretin neurons after traumatic brain injury in mice. Sleep
Reidling JC, Relaño-Ginés A, Holley SM, et al. (2017) Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice. Stem Cell Reports
Parievsky A, Moore C, Kamdjou T, et al. (2017) Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease. Neurobiology of Disease. 108: 29-44
Bentea E, Moore C, Deneyer L, et al. (2017) Plastic changes at corticostriatal synapses predict improved motor function in a partial lesion model of Parkinson's disease. Brain Research Bulletin
Hood RL, Liguore WA, Moore C, et al. (2016) Exercise intervention increases spontaneous locomotion but fails to attenuate dopaminergic system loss in a progressive MPTP model in aged mice. Brain Research
Tamburrino A, Churchill MJ, Wan OW, et al. (2015) Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's disease. Acta Neuropathologica Communications. 3: 84
Pflibsen L, Stang KA, Sconce MD, et al. (2015) Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Journal of Neuroscience Research. 93: 1849-64
See more...